To elucidate a more detailed mechanism for the relationship between SGLT2 and SIRT1, we used obese-type db/db mice with diabetes treated with the SGLT2 inhibitor canagliflozin (Cana) and investigated SIRT1 and SGLT2 expressions. This evidence concerns the gene SIRT1 and diabetes mellitus.